Neurological Disorders Hypertension Cardiovascular Diseases Musculoskeletal Disorders Gastrointestinal Disorders Diabetes Obesity Cardiovascular Health Pancreatitis Arthritis Sepsis Common Ailments Osteoarthritis Dementia Respiratory Conditions Headaches Chronic Conditions Skin Conditions Cancer Hair Disorders Myocarditis Temporary Hair Loss Hearing Impairment Gynecological Conditions Liver Conditions Cystitis Sarcopenia Anaemia Seizures Pulmonary Hypertension Liver Disease Thyroid Disorders Hyperhidrosis Hypoglycemia Hypertriglyceridemia Chronic Pain Kidney Stones Obstructive Sleep Apnea Hair Loss Myths Eye Health Types of Hair Loss Hair Loss Vision Loss Men's Health Angina Nutritional Deficiencies Common Health Issues Respiratory Issues Respiratory Infections Alopecia Neurofibromatosis Nerve Pain Mouth Ulcers Brain Tumors Hemophilia Heart Disease Strokes Inflammatory Bowel Disease Heart disease Vision Disorders Dermatology Stomach Issues Gallstones Eye Conditions Spinal Conditions Pericarditis Endometriosis Autoimmune Diseases Bone Health Long COVID Normal Pressure Hydrocephalus Urinary Tract Infections Pulmonary Conditions Genetic Disorders Maternal Health Epilepsy Women's Health Hidrocefalia Paralysis Sinusitis Skin Disorders
The company is targeting second-half 2026 global submissions after reporting a consistent safety profile.
